Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiprodil PK and safety in healthy volunteers
NCT02647697Phase 1Completed
- Sponsor
- UCB
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of radiprodil in infantile epileptic spasms syndrome (IESS), sponsored by UCB. Primary endpoints: Area under the concentration-time curve from dosing to time t at 48 hours, Apparent terminal elimination half-life at 48 hours and 6 more. Started Jan 2016; status: completed.
02
Drugs
radiprodil
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT02647697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647697.